Premier OBGYN Care

Suboxone and Pregnancy

Suboxone and Pregnancy: Understanding the Risks and Benefits

Suboxone and Pregnancy | Let’s explore the safety and considerations of using Subutex or Suboxone during pregnancy, shedding light on its role in managing opioid use disorder while expecting.

Opioid addiction and opioid use disorder pose significant challenges for pregnant women and their babies. With the prevalence of opioid use disorder among pregnant women on the rise, it’s crucial to understand the potential risks and benefits of Suboxone treatment during pregnancy. Suboxone, a combination medication containing buprenorphine and naloxone, plays a vital role in medication-assisted treatment (MAT) for opioid use disorder, offering hope for pregnant women seeking to overcome addiction while ensuring the well-being of their unborn child.

Understanding Opioid Use Disorder in Pregnancy

Opioid use disorder during pregnancy can have serious consequences for both the mother and the developing fetus. Without access to safe and effective treatment options, pregnant women with opioid use disorder are at increased risk of adverse outcomes, including neonatal abstinence syndrome (NAS), preterm birth, and low birth weight. It’s important to prioritize public health efforts aimed at addressing opioid addiction among pregnant women and providing them with comprehensive care and support throughout their pregnancy journey.

What is Suboxone?

Suboxone is a medication consisting of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. It works by binding to opioid receptors in the brain, reducing cravings and withdrawal symptoms associated with opioid use disorder. Compared to other opioid agonist therapies like methadone, Suboxone has a lower risk of misuse and overdose, making it a preferred option for pregnant women seeking treatment for opioid addiction.

suboxone and pregnancy

Safety and Considerations of Suboxone Use in Pregnancy

Research on the safety of Suboxone during pregnancy has shown promising results. Studies have indicated that Suboxone treatment is associated with improved maternal and fetal outcomes, including a reduced risk of neonatal abstinence syndrome (NAS) and neonatal complications. However, it’s essential to individualize treatment plans and closely monitor pregnant women receiving Suboxone to ensure optimal outcomes for both mother and baby.

Risks of Untreated Opioid Use Disorder During Pregnancy

Untreated opioid use disorder during pregnancy can lead to various complications, including maternal health issues, fetal distress, and an increased risk of NAS. Neonatal abstinence syndrome occurs when newborns experience withdrawal symptoms after being exposed to opioids in utero, highlighting the importance of addressing opioid addiction among pregnant women through medication-assisted treatment.

Benefits of Suboxone Treatment During Pregnancy

Suboxone treatment offers several benefits for pregnant women with opioid use disorder. It helps reduce cravings and withdrawal symptoms, allowing pregnant women to focus on their prenatal care and prepare for childbirth. By stabilizing maternal opioid dependence, Suboxone treatment can also improve neonatal outcomes and reduce the risk of NAS, providing a safer and healthier start for newborns.

Collaborative Approach to Suboxone Treatment in Pregnancy

A collaborative approach involving obstetric providers, addiction specialists, and mental health professionals is essential for providing comprehensive care to pregnant women receiving Suboxone treatment. By working together, healthcare providers can address the unique needs of pregnant women with opioid use disorder and ensure they receive the support and resources they need to achieve a successful recovery.

postpartum ocd

Counseling and Support for Pregnant Women on Suboxone

In addition to medication-assisted treatment, pregnant women receiving Suboxone should receive counseling and support to address the psychological and emotional aspects of addiction. Counseling can help pregnant women develop coping strategies, improve their self-esteem, and strengthen their support networks, enhancing their overall well-being and resilience during pregnancy and beyond.

Navigating the Challenges of Opioid Use Disorder During Pregnancy

Pregnancy can be a vulnerable time for women struggling with opioid use disorder. The physical and emotional stressors of pregnancy, combined with the challenges of managing addiction, can exacerbate feelings of anxiety, guilt, and shame. Pregnant women may also face stigma and discrimination from healthcare providers, family members, and society at large, further complicating their journey to recovery.

Breaking Down Barriers to Treatment Access

Accessing Suboxone treatment during pregnancy can be challenging due to various barriers, including limited availability of providers, insurance coverage restrictions, and transportation issues. Additionally, the stigma surrounding medication-assisted treatment may deter some pregnant women from seeking help for their addiction. Addressing these barriers requires a multi-faceted approach that involves expanding access to Suboxone providers, advocating for insurance coverage parity, and combating stigma through education and awareness campaigns.

Supporting Pregnant Women in Recovery

Supporting pregnant women in recovery goes beyond providing medication and counseling. It requires a holistic approach that addresses the social determinants of health, such as housing insecurity, food insecurity, and lack of access to childcare. Pregnant women receiving Suboxone treatment may also benefit from additional support services, such as case management, peer support groups, and assistance with navigating the healthcare system.

Addressing Neonatal Abstinence Syndrome (NAS)

Neonatal abstinence syndrome (NAS) is a withdrawal syndrome that occurs in newborns exposed to opioids in utero. While Suboxone treatment can reduce the severity of NAS symptoms, some infants may still experience withdrawal after birth. Providing specialized care for newborns with NAS, including pharmacologic treatment, supportive care, and developmental support, is essential for ensuring the best possible outcomes for these infants.

Empowering Pregnant Women in Recovery

Empowering pregnant women in recovery involves empowering them to make informed decisions about their health and the health of their babies. This includes providing accurate information about the risks and benefits of Suboxone treatment, supporting their autonomy in treatment decisions, and respecting their rights as patients. By empowering pregnant women in recovery, we can help them regain control of their lives and build a brighter future for themselves and their families.

Suboxone treatment offers hope for pregnant women struggling with opioid use disorder, providing a safe and effective option for managing addiction during pregnancy. By addressing the unique needs of pregnant women in recovery, expanding access to Suboxone treatment, and providing comprehensive support services, we can help improve maternal and neonatal outcomes and break the cycle of addiction for future generations.

Suboxone and Pregnancy Frequently Asked Questions

While Suboxone is generally considered safer than other opioids during pregnancy, its use should still be carefully considered and monitored by a healthcare provider experienced in treating opioid use disorder during pregnancy. Research on the safety of Suboxone during pregnancy is limited, but available studies suggest that it may be associated with better maternal and neonatal outcomes compared to full opioid agonists.

Yes, buprenorphine maintenance is a common treatment approach for pregnant individuals with opioid use disorder. Buprenorphine is considered one of the preferred medications for medication-assisted treatment (MAT) during pregnancy due to its safety profile compared to other opioids.

Several drugs should generally be avoided during pregnancy due to the potential risks they pose to the developing baby.

These include: Accutane (isotretinoin), thalidomide, warfarin, methotrexate, ACE inhibitors and ARBs, tetracycline antibiotics, and certain herbal supplements such as St. John’s Wort, echinacea, and ginseng. These medications have been associated with a range of adverse effects, including birth defects, developmental abnormalities, and miscarriage, and should not be used during pregnancy unless specifically prescribed and monitored by a healthcare provider.


The use of Sublocade (extended-release buprenorphine injection) during pregnancy is not recommended without careful consideration and consultation with healthcare professionals. While Sublocade is a medication used for the treatment of opioid use disorder, its safety during pregnancy has not been well-established through clinical studies.

Beyond Addiction

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Articles